期刊文献+

中国甲型肝炎减毒活疫苗和灭活疫苗免疫效果与安全性评价 被引量:13

Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China
原文传递
导出
摘要 目的评价中国甲型肝炎(甲肝)减毒活疫苗(HepA—L)和甲肝灭活疫苗(HepA—I)的安全性及免疫效果,为甲肝暴发疫情疫苗应急接种提供参考依据。方法用美国雅培(Abbott)公司生产的抗甲肝病毒抗体(抗-HAV)试剂筛查未感染HAV的6~9岁儿童。将入选对象随机分为4组,分别接种国产HepA—L和HepA—I,以国产重组乙肝疫苗(酿酒酵母)(HepB—SCY)为阴性对照,GlaxoSmithKlineBiologicalsS.A.(GsK)生产的HepA-I为阳性对照,采取随机双盲方法观察接种疫苗扁30min及24、48、72h的不良反应发生率。采用美国AbbottLaboratories生产的HAVAB2.0试剂,利用微粒子酶免疫分析与电化学发光免疫测定法(MEIA)检测1、2、4周以及12个月的HAV-IgG抗体水平。结果各组未发现严重不良反应,不良反应主要表现为发热、接种部位疼痛、硬结等。国产HepA.L和HepA—I组不良反应发生率分别为13.95%和15.25%,阳性对照组为16.80%,阴性对照组为25,62%,各组间差异无统计学意义。接种2周后,国产HepA—L和HepA—I抗体阳转率分别为85.00%和94.59%;接种后第4周,抗体阳转率达到100%;接种2、4、12周时试验组、阳性对照组HAV-IgG抗体水平高于阴性对照组;接种12个月后,国产HepA—I组甲肝抗体水平高于阳性对照组。结论国产HepA—L和HepA—I以及进LlHepA—I安全性良好,均具有较好的免疫效果。 Objective To evaluate the safety of both domestic live attenuated and inactivated hepatitis A vaccines, and to provide reference for emergent vaccination after hepatitis A outbreaks. Methods 493 children aged 6-9 with negative antibody to HAV (produced by Abbott) were randomly divided into four groups as vaccinated with domestic live attenuated hepatitis A vaccine (Group A) , domestic inactivated hepatitis A vaccine (Group B) , imported inactivated hepatitis A vaccine (Group C) and hepatitis B vaccine (Group D) respectively. Adverse events following the immunization were observed 30 minutes, 24, 48 and 72 hours after the vaccination, under double- blind method. Results The main AEFIs were: fever, local pain and scleroma but no other severe AEFIs were obvserved. The rates of AEFIs were 13.95% in Group A, 15.25% in group B, 16.80% in group C and 25.62% in group D, with no statistical differences between these groups (x^2=6.953, P〉 0.05 ). 2 weeks after the vaccination, the positive conversion rates of domestic live attenuated hepatitis A vaccine and domestic inactivated hepatitis A vaccine were 85.00% and 94.59% respectively. The rate of domestic inactivated hepatitis A vaccine reached 100% at 4 weeks after the vaccination. The antibody levels of HAV-IgG of Group A and B in 2, 4 and 12 weeks of vaccination and of Group C were higher than that of Group D. After 12 weeks of vaccination, the antibody level of group B became higher than it was Group C. Conclusion There were no differences on safety among domestic live attenuated hepatitis A vaccine, domestic inactivated hepatitis A vaccine or imported inactivated hepatitis A vaccine under routine or emergency vaccination. All the vaccines showed satisfactory effects.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2013年第1期24-27,共4页 Chinese Journal of Epidemiology
基金 基金项目:国家科技重大专项(2008BAl56800)
关键词 甲型肝炎疫苗 安全性 免疫原性 Hepatitis A vaccine Safety Immunogenicity
  • 相关文献

参考文献11

二级参考文献92

共引文献63

同被引文献139

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部